Skip to content

Effect of Unani formulation in Ring worm

Therapeutic evaluation of Topical Halela Zard in treatment of Quba (Tinea Corporis) - A randomised Standard Controlled Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030404
Enrollment
40
Registered
2021-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Halela Zard and Sirka: Halela Zard will be procured from the registered herbalist and will be subjected to taxonomical identification by certified botanist. Then, the ingredient will be

Sponsors

Luqman Unani Medical College Hospital and Research Center Vijaypur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically as well as KOH diagnosed cases of Tinea corporis without nail and scalp involvement with Body Surface Area less than or equal to 20%

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Patient already on topical and/or systemic antifungal treatment (1 week of topical therapy and/or 4 weeks of systemic antifungal therapy before baseline visit) Diabetes mellitus Patients with immunosuppressive disease/drugs Super-imposed cases of tinea corporis Non-compliance to the trial protocol

Design outcomes

Primary

MeasureTime frame
KOH examinationTimepoint: At baseline and After completion of therapy

Secondary

MeasureTime frame
Change in pruritus measured by VASTimepoint: At baseline, 10th, 20th, 30th, and 40th day;Dermatology Life quality indexTimepoint: Baseline and after trial;Patients global assessmentTimepoint: Baseline and after trial;Physicians global assessmentTimepoint: Baseline and after trial

Countries

India

Contacts

Public ContactNazim Husain

Luqman Unani Medical College

khalidhameedkhan@gmail.com9916261251

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026